introducing molecular diagnostics to improve leukemia care in developing countries
Published 3 weeks ago • 39 plays • Length 2:06Download video MP4
Download video MP3
Similar videos
-
1:31
how the treatment and management of all changes with age
-
3:25
how have leukemia diagnostics and management evolved?
-
1:00
proof of principle to progress treatments
-
2:45
safety and efficacy of inotuzumab ozogamicin conditioning for allosct in lymphoid malignancies
-
3:08
welcome to the video journal of hematology & hematological oncology 🎥🩸
-
1:23
the current landscape of treatment for hr-mds: an update from ash 2023
-
14:43
current research into post-allosct maintenance therapy in aml
-
9:25
mgus diagnosis: a step-by-step approach
-
4:44
7-year update on a phase ii trial of fixed-duration obinutuzumab, ibrutinib, and venetoclax for cll
-
2:22
the need for novel agents to treat patients with mcl who have relapsed after targeted therapy
-
1:59
assessing if a patient with dlbcl is responding to treatment using pet-ct and novel assays
-
2:45
an insight into clinical risk factors for progression in mpns
-
1:47
advances in hodgkin lymphoma treatment: moving away from abvd and beacopp
-
4:48
the evolution of allosct in richter's transformation and its combination with biological agents
-
1:42
the future of cll treatment: aiming for long-lasting remission
-
3:37
the future of aml treatment
-
3:37
progress in the categorization and treatment of lr-mds
-
2:48
the promise of pyruvate kinase activators, such as mitapivat, for treating scd and thalassemia
-
2:18
treating patients with advanced-stage hl in the frontline and relapsed settings in 2024
-
5:02
advances in the treatment of all: how far have we come?
-
0:56
microbiota in hematologic malignancies